Skip to main content

Nasonex 24HR Allergy FDA Approval History

FDA Approved: Yes (First approved March 17, 2022)
Brand name: Nasonex 24HR Allergy
Generic name: mometasone furoate monohydrate
Dosage form: Nasal Spray
Company: Perrigo Company
Treatment for: Allergic Rhinitis

Nasonex 24HR Allergy (mometasone furoate monohydrate) is a corticosteroid nasal spray available over-the-counter for the temporary relief of the symptoms of hayfever or other upper respiratory allergies.

  • Perrigo expects to begin offering Nasonex 24HR Allergy later in 2022.

Development timeline for Nasonex 24HR Allergy

Mar 17, 2022Approval FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.